Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.595
-0.075 (-2.81%)
Dec 15, 2025, 2:53 PM EST - Market open

Perspective Therapeutics Revenue

Perspective Therapeutics had revenue of $209.00K in the quarter ending September 30, 2025, a decrease of -43.36%. This brings the company's revenue in the last twelve months to $1.08M, down -30.96% year-over-year. In the year 2024, Perspective Therapeutics had annual revenue of $1.45M with 1.39% growth.

Revenue (ttm)
$1.08M
Revenue Growth
-30.96%
P/S Ratio
181.15
Revenue / Employee
$7,679
Employees
140
Market Cap
192.91M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.45M20.00K1.39%
Dec 31, 20231.43M--
Dec 31, 2022---
Sep 30, 202210.80M--
Jun 30, 2022---
Jun 30, 202110.05M373.00K3.85%
Jun 30, 20209.68M2.37M32.35%
Jun 30, 20197.31M1.39M23.48%
Jun 30, 20185.92M1.16M24.41%
Jun 30, 20174.76M-8.00K-0.17%
Jun 30, 20164.77M163.00K3.54%
Jun 30, 20154.61M386.84K9.17%
Jun 30, 20144.22M-306.08K-6.76%
Jun 30, 20134.53M-545.86K-10.76%
Jun 30, 20125.07M-167.89K-3.20%
Jun 30, 20115.24M-47.11K-0.89%
Jun 30, 20105.29M-131.73K-2.43%
Jun 30, 20095.42M-1.74M-24.32%
Jun 30, 20087.16M1.42M24.76%
Jun 30, 20075.74M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings